


| Key | % Net Assets |
|---|---|
| 3.9% | |
| 3.3% | |
| 3.1% | |
| 3.0% | |
| 86.7% |
| Name | % Net Assets |
|---|---|
| Exxon Mobil | 3.9% |
| Microsoft | 3.3% |
| Merck & Co | 3.1% |
| Cisco Systems | 3.0% |
| Abbott Laboratories | 2.5% |
| Procter & Gamble | 2.4% |
| Merck & Co | 2.2% |
| Hewlett Packard | 2.1% |
| Abbott Laboratories | 1.9% |
| Chevron | 1.9% |
No asset data available.
| Date | 09-Sep-2022 |
|---|---|
| NAV | 305.70p |
| Currency | GBP |
| Change | 1.10p |
| % | 0.36% |
| YTD change | 305.70p |
| YTD % | n/a |
| Fund Inception | 01/07/1995 |
|---|---|
| Fund Manager | Tom Luddy / Susan Bao |
| TER | 1.68 (31-Jan-2013) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £100 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research